Michael Davis - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Behavior

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Cole KE, Lee J, Davis M, Parsons RG. Subthreshold fear conditioning produces a rapidly developing neural mechanism that primes subsequent learning. Eneuro. PMID 31221863 DOI: 10.1523/ENEURO.0113-19.2019  1
2017 Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, ... ... Davis M, et al. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 28122091 DOI: 10.1001/jamapsychiatry.2016.3955  1
2016 Wheeler MG, Duncan E, Davis M. Low Startle Magnitude May Be a Behavioral Marker of Vulnerability to Cocaine Addiction. Synapse (New York, N.Y.). PMID 27696533 DOI: 10.1002/syn.21943  0.6
2016 Parsons RG, Walker DL, Davis M. Mechanisms underlying long-term fear memory formation from a metaplastic neuronal state. Neurobiology of Learning and Memory. PMID 27660077 DOI: 10.1016/j.nlm.2016.09.009  1
2016 Hong K, Zhao G, Hong Z, Sun Z, Yang Y, Clifford PS, Davis MJ, Meininger GA, Hill MA. Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles. The Journal of Physiology. PMID 27531064 DOI: 10.1113/JP272834  0.64
2016 Kostereva NV, Wang Y, Fletcher DR, Unadkat JV, Schnider JT, Komatsu C, Yang Y, Stolz DB, Davis MR, Plock JA, Gorantla VS. IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation. Plos One. 11: e0156149. PMID 27272754 DOI: 10.1371/journal.pone.0156149  0.64
2016 Norrholm SD, Jovanovic T, Gerardi M, Breazeale KG, Price M, Davis M, Duncan E, Ressler KJ, Bradley B, Rizzo A, Tuerk PW, Rothbaum BO. Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. Behaviour Research and Therapy. 82: 28-37. PMID 27183343 DOI: 10.1016/j.brat.2016.05.002  0.4
2015 Miller BF, Ehrlicher SE, Drake JC, Peelor FF, Biela LM, Pratt-Phillips S, Davis M, Hamilton KL. Assessment of protein synthesis in highly aerobic canine species at the onset and during exercise training. Journal of Applied Physiology (Bethesda, Md. : 1985). 118: 811-7. PMID 25614602 DOI: 10.1152/japplphysiol.00982.2014  0.48
2015 Drum MG, Marcellin-Little DJ, Davis MS. Principles and applications of therapeutic exercises for small animals. The Veterinary Clinics of North America. Small Animal Practice. 45: 73-90. PMID 25432682 DOI: 10.1016/j.cvsm.2014.09.005  0.48
2015 Miller BF, Drake JC, Peelor FF, Biela LM, Geor R, Hinchcliff K, Davis M, Hamilton KL. Participation in a 1,000-mile race increases the oxidation of carbohydrate in Alaskan sled dogs. Journal of Applied Physiology (Bethesda, Md. : 1985). 118: 1502-9. PMID 25150223 DOI: 10.1152/japplphysiol.00588.2014  0.48
2014 Davis MS, Bonen A, Snook LA, Jain SS, Bartels K, Geor R, Hueffer K. Conditioning increases the gain of contraction-induced sarcolemmal substrate transport in ultra-endurance racing sled dogs. Plos One. 9: e103087. PMID 25075856 DOI: 10.1371/journal.pone.0103087  0.48
2014 Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B, Davis M, Bradley B, Duncan EJ, Rizzo A, Ressler KJ. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. The American Journal of Psychiatry. 171: 640-8. PMID 24743802 DOI: 10.1176/appi.ajp.2014.13121625  1
2014 Davis MC, Green MF, Lee J, Horan WP, Senturk D, Clarke AD, Marder SR. Oxytocin-augmented social cognitive skills training in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2070-7. PMID 24637803 DOI: 10.1038/npp.2014.68  0.32
2014 Kazama AM, Davis M, Bachevalier J. Neonatal lesions of orbital frontal areas 11/13 in monkeys alter goal-directed behavior but spare fear conditioning and safety signal learning. Frontiers in Neuroscience. 8: 37. PMID 24624054 DOI: 10.3389/fnins.2014.00037  1
2014 Davis M, Walker DL. Role of bed nucleus of the stria terminalis and amygdala AMPA receptors in the development and expression of context conditioning and sensitization of startle by prior shock. Brain Structure & Function. 219: 1969-82. PMID 23934654 DOI: 10.1007/s00429-013-0616-5  1
2013 Sink KS, Davis M, Walker DL. CGRP antagonist infused into the bed nucleus of the stria terminalis impairs the acquisition and expression of context but not discretely cued fear. Learning & Memory (Cold Spring Harbor, N.Y.). 20: 730-9. PMID 24255102 DOI: 10.1101/lm.032482.113  1
2013 Glover EM, Mercer KB, Norrholm SD, Davis M, Duncan E, Bradley B, Ressler KJ, Jovanovic T. Inhibition of fear is differentially associated with cycling estrogen levels in women. Journal of Psychiatry & Neuroscience : Jpn. 38: 341-8. PMID 23611176 DOI: 10.1503/jpn.120129  1
2013 Kazama AM, Schauder KB, McKinnon M, Bachevalier J, Davis M. A novel AX+/BX- paradigm to assess fear learning and safety-signal processing with repeated-measure designs. Journal of Neuroscience Methods. 214: 177-83. PMID 23376500 DOI: 10.1016/j.jneumeth.2013.01.022  1
2013 Gutman DA, Magnuson M, Majeed W, Keifer OP, Davis M, Ressler KJ, Keilholz S. Mapping of the mouse olfactory system with manganese-enhanced magnetic resonance imaging and diffusion tensor imaging. Brain Structure & Function. 218: 527-37. PMID 22527121 DOI: 10.1007/s00429-012-0413-6  1
2012 Rothbaum BO, Kearns MC, Price M, Malcoun E, Davis M, Ressler KJ, Lang D, Houry D. Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biological Psychiatry. 72: 957-63. PMID 22766415 DOI: 10.1016/j.biopsych.2012.06.002  1
2012 Parsons RG, Davis M. A metaplasticity-like mechanism supports the selection of fear memories: role of protein kinase a in the amygdala. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7843-51. PMID 22674260 DOI: 10.1523/JNEUROSCI.0939-12.2012  1
2012 Kazama AM, Heuer E, Davis M, Bachevalier J. Effects of neonatal amygdala lesions on fear learning, conditioned inhibition, and extinction in adult macaques. Behavioral Neuroscience. 126: 392-403. PMID 22642884 DOI: 10.1037/a0028241  1
2011 Glover EM, Phifer JE, Crain DF, Norrholm SD, Davis M, Bradley B, Ressler KJ, Jovanovic T. Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures. Depression and Anxiety. 28: 1058-66. PMID 21898707 DOI: 10.1002/da.20880  1
2011 Parsons RG, Davis M. Gone but not Forgotten. Frontiers in Behavioral Neuroscience. 5: 51. PMID 21887139 DOI: 10.3389/fnbeh.2011.00051  1
2011 Miles L, Davis M, Walker D. Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1563-74. PMID 21471958 DOI: 10.1038/npp.2011.29  1
2011 Sink KS, Walker DL, Yang Y, Davis M. Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1802-10. PMID 21289190 DOI: 10.1523/JNEUROSCI.5274-10.2011  1
2011 Parsons RG, Davis M. Temporary disruption of fear-potentiated startle following PKMζ inhibition in the amygdala. Nature Neuroscience. 14: 295-6. PMID 21258326 DOI: 10.1038/nn.2745  1
2010 Glover EM, Ressler KJ, Davis M. Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learning & Memory (Cold Spring Harbor, N.Y.). 17: 577-81. PMID 21036892 DOI: 10.1101/lm.1908310  1
2010 Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ. Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety. 27: 244-51. PMID 20143428 DOI: 10.1002/da.20663  1
2010 Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 105-35. PMID 19693004 DOI: 10.1038/npp.2009.109  1
2009 Heldt SA, Davis M, Ratti E, Corsi M, Trist D, Ressler KJ. Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils. Behavioural Pharmacology. 20: 584-95. PMID 19675456 DOI: 10.1097/FBP.0b013e32832ec594  1
2009 Walker D, Yang Y, Ratti E, Corsi M, Trist D, Davis M. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1533-42. PMID 19078950 DOI: 10.1038/npp.2008.210  1
2009 Chhatwal JP, Gutman AR, Maguschak KA, Bowser ME, Yang Y, Davis M, Ressler KJ. Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 509-21. PMID 18580872 DOI: 10.1038/npp.2008.97  1
2009 Zhao Z, Yang Y, Walker DL, Davis M. Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 331-40. PMID 18418359 DOI: 10.1038/npp.2008.55  1
2008 Jones SV, Choi DC, Davis M, Ressler KJ. Learning-dependent structural plasticity in the adult olfactory pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13106-11. PMID 19052201 DOI: 10.1523/JNEUROSCI.4465-08.2008  1
2008 Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12682-90. PMID 19036961 DOI: 10.1523/JNEUROSCI.2305-08.2008  1
2008 Walker DL, Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Structure & Function. 213: 29-42. PMID 18528706 DOI: 10.1007/s00429-008-0183-3  1
2008 Glover EM, Davis M. Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone. Psychopharmacology. 198: 167-80. PMID 18324390 DOI: 10.1007/s00213-008-1112-0  1
2008 Walker DL, Davis M. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 67-74. PMID 18230675 DOI: 10.1101/lm.798908  1
2007 Jones SV, Stanek-Rattiner L, Davis M, Ressler KJ. Differential regional expression of brain-derived neurotrophic factor following olfactory fear learning. Learning & Memory (Cold Spring Harbor, N.Y.). 14: 816-20. PMID 18086824 DOI: 10.1101/lm.781507  1
2006 Chhatwal JP, Stanek-Rattiner L, Davis M, Ressler KJ. Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nature Neuroscience. 9: 870-2. PMID 16783370 DOI: 10.1038/nn1718  1
2006 Myers KM, Ressler KJ, Davis M. Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learning & Memory (Cold Spring Harbor, N.Y.). 13: 216-23. PMID 16585797 DOI: 10.1101/lm.119806  1
2006 Davis M, Myers KM, Chhatwal J, Ressler KJ. Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 82-96. PMID 16490415 DOI: 10.1016/j.nurx.2005.12.008  1
2005 Nair HP, Gutman AR, Davis M, Young LJ. Central oxytocin, vasopressin, and corticotropin-releasing factor receptor densities in the basal forebrain predict isolation potentiated startle in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11479-88. PMID 16339041 DOI: 10.1523/JNEUROSCI.2524-05.2005  1
2005 Rattiner LM, Davis M, Ressler KJ. Brain-derived neurotrophic factor in amygdala-dependent learning. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 11: 323-33. PMID 16061519 DOI: 10.1177/1073858404272255  1
2005 Walker DL, Paschall GY, Davis M. Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression. Learning & Memory (Cold Spring Harbor, N.Y.). 12: 120-9. PMID 15774945 DOI: 10.1101/lm.87105  1
2005 Jones SV, Heldt SA, Davis M, Ressler KJ. Olfactory-mediated fear conditioning in mice: simultaneous measurements of fear-potentiated startle and freezing. Behavioral Neuroscience. 119: 329-35. PMID 15727538 DOI: 10.1037/0735-7044.119.1.329  1
2005 Chhatwal JP, Myers KM, Ressler KJ, Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 502-6. PMID 15647495 DOI: 10.1523/JNEUROSCI.3301-04.2005  1
2005 Chhatwal JP, Davis M, Maguschak KA, Ressler KJ. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 516-24. PMID 15637635 DOI: 10.1038/sj.npp.1300655  1
2005 Josselyn SA, Falls WA, Gewirtz JC, Pistell P, Davis M. The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 17-26. PMID 15257308 DOI: 10.1038/sj.npp.1300530  1
2004 Rattiner LM, Davis M, Ressler KJ. Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learning & Memory (Cold Spring Harbor, N.Y.). 11: 727-31. PMID 15537738 DOI: 10.1101/lm.83304  1
2004 Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Archives of General Psychiatry. 61: 1136-44. PMID 15520361 DOI: 10.1001/archpsyc.61.11.1136  1
2004 Rattiner LM, Davis M, French CT, Ressler KJ. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4796-806. PMID 15152040 DOI: 10.1523/JNEUROSCI.5654-03.2004  1
2004 Walker DL, Davis M. Are fear memories made and maintained by the same NMDA receptor-dependent mechanisms? Neuron. 41: 680-2. PMID 15003167 DOI: 10.1016/S0896-6273(04)00114-X  1
2004 Meloni EG, Davis M. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats. Psychopharmacology. 174: 228-36. PMID 14735289 DOI: 10.1007/s00213-003-1728-z  1
2003 Davis M, Walker DL, Myers KM. Role of the amygdala in fear extinction measured with potentiated startle. Annals of the New York Academy of Sciences. 985: 218-32. PMID 12724161  1
2003 Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. European Journal of Pharmacology. 463: 199-216. PMID 12600711 DOI: 10.1016/S0014-2999(03)01282-2  1
2002 Walker DL, Rattiner LM, Davis M. Group II metabotropic glutamate receptors within the amygdala regulate fear as assessed with potentiated startle in rats. Behavioral Neuroscience. 116: 1075-83. PMID 12492306 DOI: 10.1037//0735-7044.116.6.1075  1
2002 Walker DL, Davis M. Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology. 164: 318-28. PMID 12424556 DOI: 10.1007/s00213-002-1213-0  1
2002 Ressler KJ, Paschall G, Zhou XL, Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7892-902. PMID 12223542  1
2002 Walker DL, Ressler KJ, Lu KT, Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2343-51. PMID 11896173  1
2002 Walker DL, Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology. 159: 304-10. PMID 11862363 DOI: 10.1007/s002130100913  1
2002 Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacology, Biochemistry, and Behavior. 71: 379-92. PMID 11830172 DOI: 10.1016/S0091-3057(01)00698-0  1
Show low-probability matches.